| Views | |
|---|---|
| FOLFIRI plus cetuximab or bevacizumab for advanced colorectal cancer: final survival and per-protocol analysis of FIRE-3, a randomised clinical trial | 180 |
| March 2025 | April 2025 | May 2025 | June 2025 | July 2025 | August 2025 | September 2025 | |
|---|---|---|---|---|---|---|---|
| FOLFIRI plus cetuximab or bevacizumab for advanced colorectal cancer: final survival and per-protocol analysis of FIRE-3, a randomised clinical trial | 5 | 14 | 1 | 4 | 5 | 5 | 12 |
| Views | |
|---|---|
| 2020_Heinemann_etal.pdf | 122 |
